This prospective cohort study aims to investigate the impact of early antibiotic exposure on the establishment of gut microbiota and motility in newborns, particularly preterm infants. The study will explore the correlation between antibiotic exposure, gut microbiota colonization, and 5-hydroxytryptamine (5-HT) levels, which are critical for gastrointestinal motility. The findings may provide insights into optimizing antibiotic use and improving gastrointestinal health in neonates.
Eligibility
Sex
ALL
Min age
24 Weeks
Max age
36 Weeks
Healthy volunteers
No
Inclusion Criteria:
* Newborns admitted within 72 hours of birth
* Gestational age 24-36 weeks (preterm) and term infants
* Informed consent obtained from parents or guardian
Exclusion Criteria:
* Congenital gastrointestinal malformations (e.g., intestinal atresia, Hirschsprung's disease)
* Severe systemic or organ-specific diseases
* Expected mortality due to severe illness
Primary outcome measure(s)
gut microbiota — Enrollment Period: This is the time during which participants will be recruited and enrolled into the study. You have specified that enrollment will occur from November 2024 to November 2027. Intervention Period: Since this is an observational study, the Impact of antibiotic exposure on gut microbiota colonization assessed by 16S rRNA sequencing.
Trial sites (1)
Facility
City
Region
Status
The first hospital of Jilin university
Changchun
Jilin
More The First Hospital of Jilin University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.